Skip to content
sellModerate

Ra Capital Management, L.p. sold $22M of SION

director, owner at Sionna Therapeutics, Inc.. 3,448,811 shares at an average of $6.33, traded Sep 17, 2026, filed Sep 21, 2026.

Warning score
50
Value
$22M
3,448,811 shares
Holdings after
3,448,812
-50% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $21.8M at market
    +25
  • Share of holdings sold
    Sold 50% of holdings
    +10
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

SIONOct 9, 2026 · close 4.90
Since filing Sep 21, 2026: -18.3%SPY +0.7% · excess -19.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001231919-26-001201, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 17, 2026SOpen-market sale
Common Stockindirect: See footnotes
-3,415,011$6.32$22M3,482,61221 d ago
Sep 17, 2026SOpen-market sale
Common Stockindirect: See footnotes
-33,800$7.46$252k3,448,81221 d ago

Related signals

Other insiders at Sionna Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
53Moderate
SIONbuy 4
Sionna Therapeutics, Inc.
Tpg Gp A, LLC
owner
$20M
1,125,000 shares
+20%
50Moderate
SIONbuy 4
Sionna Therapeutics, Inc.
Atlas Venture Fund XI, L.P.
owner
$1.1M
60,000 shares
+8%
58Moderate
SIONbuy 4
Sionna Therapeutics, Inc.
Bruce Booth
director
$1.1M
60,000 shares
+8%
58Moderate
SIONbuy 4
Sionna Therapeutics, Inc.
Ra Capital Management, L.p.
director, owner
$20M
1,125,000 shares
+19%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Ra Capital Management, L.p. sold $22M of SION | InsiderTell